BRAF inhibitor-driven tumor proliferation in akras-mutated colon carcinoma is not overcome by mek1/2 inhibition

Miles C. Andrews, Andreas Behren, Fiona Chionh, John Mariadason, Laura J. Vella, Hongdo Do, Alexander Dobrovic, Niall Tebbutt, Jonathan Cebon

Research output: Contribution to journalArticleOtherpeer-review

41 Citations (Scopus)
Original languageEnglish
Pages (from-to)e448-e451
Number of pages4
JournalJournal of Clinical Oncology
Volume31
Issue number35
DOIs
Publication statusPublished - 10 Dec 2013
Externally publishedYes

Cite this

Andrews, M. C., Behren, A., Chionh, F., Mariadason, J., Vella, L. J., Do, H., Dobrovic, A., Tebbutt, N., & Cebon, J. (2013). BRAF inhibitor-driven tumor proliferation in akras-mutated colon carcinoma is not overcome by mek1/2 inhibition. Journal of Clinical Oncology, 31(35), e448-e451. https://doi.org/10.1200/JCO.2013.50.4118